AKCEA-ANGPTL3-LRx (ISIS 703802)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AKCEA-ANGPTL3-LRx (ISIS 703802), covering 2021-01-07 to 2021-01-07. Get the full timeline:
Most recent: Clinical Trial Update: Phase 2 Study of AKCEA-ANGPTL3-LRx (ISIS 703802) in Participants With Familial Chylomicronemia Syndrome (FCS) [Phase 2]